Cytomedix to Present At Rodman & Renshaw 10th Annual Healthcare Conference On Wednesday, Nov. 12, 2008
October 20, 2008 08:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 20, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Chief Executive Officer Martin Rosendale will present an overview of the Company at the Rodman &...
Cytomedix On Track With Sales and Marketing Efforts for AutoloGel System and Further Development of CT-112 Peptide, Annual Meeting Told
September 19, 2008 13:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) Chief Executive Officer Martin Rosendale told the Annual Meeting of Shareholders today that the Company is progressing...
Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development
September 10, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 10, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced the appointment of Dr. Peter Anton Clausen, Ph.D., a seasoned biochemist with nearly 15 years experience...
Cytomedix Completes $1.5 Million Capital Raise
September 08, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 8, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has successfully completed a $1.5 million capital raise through the issuance of two million shares...
Cytomedix CEO Martin Rosendale Discusses Company in Interview With The Wall Street Transcript
August 19, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that The Wall Street Transcript (TWST) has published an in-depth interview with Chief Executive Officer...
Cytomedix Retains Dr. David F. Counts, Inventor of Company's Anti-Inflammatory Peptide Patent
July 28, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., July 28, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that David F. Counts Ph.D., a leading pharmacologist and medical researcher who discovered the Company's...
Cytomedix CEO Issues Shareholder Update
July 16, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., July 16, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) announced today that Chief Executive Officer Martin Rosendale issued the following letter to shareholders providing a...
Cytomedix Unveils Clinical Plans for the Development of Anti-Inflammatory Peptides
June 12, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., June 12, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced plans for entering the multi-billion dollar anti-inflammatory market with patent protected peptides derived...
Cytomedix Announces Transition of Leadership
June 09, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., June 9, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Kshitij Mohan, Ph.D. will step down as Chairman and CEO effective June 30, 2008, but will continue as a...
Cytomedix Joins the Acute Long Term Hospital Association (ALTHA) as An Allied Member
May 14, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., May 14, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has joined the Acute Long Term Hospital Association (ALTHA) as a Silver member and will be...